Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

PubMed Links for Books (Select 2876894)

1.

Copper-free click--a promising tool for pre-targeted PET imaging.

Evans HL, Slade RL, Carroll L, Smith G, Nguyen QD, Iddon L, Kamaly N, Stöckmann H, Leeper FJ, Aboagye EO, Spivey AC.

Chem Commun (Camb). 2012 Jan 25;48(7):991-3. doi: 10.1039/c1cc16220a. Epub 2011 Dec 7.

PMID:
22158912
2.

Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.

Teunissen JJ, Kwekkeboom DJ, Valkema R, Krenning EP.

Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S27-51. doi: 10.1530/ERC-10-0282. Print 2011 Oct. Review.

3.

Targeting somatostatin receptors: preclinical evaluation of novel 18F-fluoroethyltriazole-Tyr3-octreotate analogs for PET.

Leyton J, Iddon L, Perumal M, Indrevoll B, Glaser M, Robins E, George AJ, Cuthbertson A, Luthra SK, Aboagye EO.

J Nucl Med. 2011 Sep;52(9):1441-8. doi: 10.2967/jnumed.111.088906. Epub 2011 Aug 18.

4.

Synthesis and in vitro evaluation of [18F]fluoroethyl triazole labelled [Tyr3]octreotate analogues using click chemistry.

Iddon L, Leyton J, Indrevoll B, Glaser M, Robins EG, George AJ, Cuthbertson A, Luthra SK, Aboagye EO.

Bioorg Med Chem Lett. 2011 May 15;21(10):3122-7. doi: 10.1016/j.bmcl.2011.03.016. Epub 2011 Mar 30.

PMID:
21458258
5.

Molecular imaging of gastroenteropancreatic neuroendocrine tumors.

Miederer M, Weber MM, Fottner C.

Gastroenterol Clin North Am. 2010 Dec;39(4):923-35. doi: 10.1016/j.gtc.2010.08.031. Epub 2010 Oct 8. Review.

PMID:
21093764
6.

Gastroenteropancreatic neuroendocrine tumours.

Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A.

Lancet Oncol. 2008 Jan;9(1):61-72. doi: 10.1016/S1470-2045(07)70410-2. Review.

PMID:
18177818
7.

Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide.

Meisetschläger G, Poethko T, Stahl A, Wolf I, Scheidhauer K, Schottelius M, Herz M, Wester HJ, Schwaiger M.

J Nucl Med. 2006 Apr;47(4):566-73.

8.

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data.

Hofmann M, Maecke H, Börner R, Weckesser E, Schöffski P, Oei L, Schumacher J, Henze M, Heppeler A, Meyer J, Knapp H.

Eur J Nucl Med. 2001 Dec;28(12):1751-7. Epub 2001 Oct 31.

PMID:
11734911
9.

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, van Hagen M, Postema PT, de Jong M, Reubi JC, et al.

Eur J Nucl Med. 1993 Aug;20(8):716-31. Review.

PMID:
8404961
10.

Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin.

Krenning EP, Bakker WH, Breeman WA, Koper JW, Kooij PP, Ausema L, Lameris JS, Reubi JC, Lamberts SW.

Lancet. 1989 Feb 4;1(8632):242-4.

PMID:
2563413
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk